WHITFIELD ROY A
SEC CIK 936728 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | Dir | 216.2K | — | $17.1K | 4 | 2021-09-16 | 2023-06-14 |
Most active insiders at NKTR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBIN HOWARD W | Pres, CEO, Dir | — | $1.42M |
| 2 | Zalevsky Jonathan | Chief R, D Off | — | $974.2K |
| 3 | Wilson Mark Andrew | CLO | — | $34.2K |
WHITFIELD ROY A made no open-market trades at NKTR in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-15 | 2023-06-14 | NKTR | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Dir | S - Sale | $0.57 | -30.0K | 216.2K | -12% | -$17.1K | |
| D | 2022-09-20 | 2022-09-16 | NKTR | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Dir | A - Grant | $0.00 | +10.2K | 246.2K | +4% | $0 |
| D | 2021-09-24 | 2021-09-22 | NKTR | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Dir | A - Grant | $0.00 | +10.2K | 236.1K | +5% | $0 |
| D | 2021-09-17 | 2021-09-16 | NKTR | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Dir | M - OptEx | $13.80 | +40.0K | 225.8K | +22% | +$552.0K |
Purchase Sale Sale after option exercise All abbreviations